On April 15, a federal court judge said that the Food and Drug Administration (FDA) will have to report when it expects to take action on the vaping products with the largest market share.
Paul W. Grimm, a judge in the United States District Court for the District of Maryland, granted a motion filed by American Academy of Pediatrics (AAP) and other plaintiffs—many of them public health groups hostile to vaping—that requires the FDA to “forecast the percentages of such products for which it expects to have taken ‘action’ by June 2022 and quarterly thereafter.”
The first report must be sent to the court and plaintiffs in two weeks, and every 90 days after that.
The decision is something of a rarity in tobacco control—transparency about a process that has been decidedly opaque, and from which all parties could now potentially stand to benefit.
Alex Norcia -Filter – 2022-04-15
Want More Investigative Content?
